Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

[1]  R. Califf,et al.  Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. , 2015, JACC. Heart failure.

[2]  P. D. De Jager,et al.  Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. , 2014, Journal of the American Society of Nephrology : JASN.

[3]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[4]  Adrian F Hernandez,et al.  Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. , 2013, JAMA.

[5]  W. W. Tang,et al.  Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure. , 2013, Journal of cardiac failure.

[6]  E. Vittinghoff,et al.  Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation , 2013, Biomarker insights.

[7]  K. Anstrom,et al.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome. , 2012, The New England journal of medicine.

[8]  S. Hazen,et al.  Cystatin C Identifies Patients With Stable Chronic Heart Failure at Increased Risk for Adverse Cardiovascular Events , 2012, Circulation. Heart failure.

[9]  M. Gheorghiade,et al.  The role of the kidney in heart failure. , 2012, European heart journal.

[10]  W. Tang,et al.  Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure , 2012, European journal of heart failure.

[11]  M. Metra,et al.  Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?: The Role of Congestion and Its Interaction With Renal Function , 2012, Circulation. Heart failure.

[12]  V. Hasselblad,et al.  Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study , 2011, European journal of heart failure.

[13]  S. Werns.  Effect of Nesiritide in Patients with Acute Decompensated Heart Failure , 2012 .

[14]  L. Tavazzi,et al.  Clinical outcome of renal tubular damage in chronic heart failure. , 2011, European heart journal.

[15]  P. van der Harst,et al.  Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure , 2011, Heart.

[16]  M. Mack,et al.  Kidney injury molecule‐1 and N‐acetyl‐ß‐d‐glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome , 2011, European journal of heart failure.

[17]  Anna Engeln.  Diuretic Strategies in Patients with Acute Decompensated Heart Failure , 2011 .

[18]  S. Kimmel,et al.  Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization. , 2011, American heart journal.

[19]  Adrian F Hernandez,et al.  Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[20]  G. Navis,et al.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate , 2010, Heart.

[21]  Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative , 2009, European heart journal.

[22]  D. J. Veldhuisen,et al.  Both in‐ and out‐hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH) , 2009, European journal of heart failure.

[23]  W. Tang,et al.  Cardiorenal syndrome in decompensated heart failure , 2009, Heart.

[24]  V. Hasselblad,et al.  Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). , 2009, American heart journal.

[25]  T. A. Sutton,et al.  Alteration of microvascular permeability in acute kidney injury. , 2009, Microvascular research.

[26]  Joseph V Bonventre,et al.  Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. , 2008, The Journal of clinical investigation.

[27]  J. Todd,et al.  Ultrasensitive flow-based immunoassays using single-molecule counting. , 2007, Clinical chemistry.

[28]  S. Solomon,et al.  Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. , 2006, Journal of the American Society of Nephrology : JASN.

[29]  Joseph V Bonventre,et al.  Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.

[30]  B. Psaty,et al.  Cystatin-C and mortality in elderly persons with heart failure. , 2005, Journal of the American College of Cardiology.

[31]  J. Bonventre,et al.  Kidney Injury Molecule-1 ( Kim-1 ) : A Tissue and Urinary Biomarker for Nephrotoxicant-Induced Renal Injury . , 2003 .

[32]  B. Molitoris,et al.  Microvascular endothelial injury and dysfunction during ischemic acute renal failure. , 2002, Kidney international.

[33]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[34]  E. Erlandsen,et al.  Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review , 1999, Clinical chemistry and laboratory medicine.

[35]  Joseph V. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.

[36]  A. Michaels,et al.  Transtubular leakage of glomerular filtrate in human acute renal failure. , 1979, The American journal of physiology.

[37]  J. Weller,et al.  Clinical evaluation of renal function. , 1960, Medical bulletin.